middle.news
Argent BioPharma Expands Portfolio with CannPal Acquisition and EU CannEpil Shipment
9:30am on Wednesday 29th of April, 2026 AEST
•
Biotechnology
Read Story
Argent BioPharma Expands Portfolio with CannPal Acquisition and EU CannEpil Shipment
9:30am on Wednesday 29th of April, 2026 AEST
Key Points
Acquisition of 48% interest in CannPal Animal Therapeutics
Largest commercial CannEpil® shipment to Ireland valued at ~A$783,000
US provisional patent filed for NanoBodies platform targeting septic shock
Operating cash outflows of A$788k; closing cash balance A$736k
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Argent Biopharma (ASX:RGT)
OPEN ARTICLE